292073-50-8

Basic information

• Product Name: Propanoic acid, 3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethyl-, methyl ester
• CAS NO: 292073-50-8
• Molecular Formula: C22H30O3Si
• Molecular Weight: 370.564
• Mol File: 292073-50-8.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Propanoic acid, 3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanoic acid, 3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethyl-, methyl ester(292073-50-8)
• EPA Substance Registry System: Propanoic acid, 3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethyl-, methyl ester(292073-50-8)

Safety Data

• Hazardous Substances Data: 292073-50-8(Hazardous Substances Data)

Upstream product

• 14002-80-3 Methyl 2,2-dimethyl-3-hydroxypropionate 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 292073-47-3 (2E)-4-{2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]thiazol-4-yl}but-2-en-1-ol 
• 292073-48-4 4-((2E)-4-bromobut-2-enyl)-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]thiazole 
• 292073-45-1 methyl 2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]thiazolidine-4-carboxylate 
• 292073-46-2 methyl 2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]thiazol-4-carboxylate 
• 136022-55-4 3-((tert-butyldiphenylsilyl)oxy)-2,2-dimethylpropanal 
• 292073-49-5 (E)-2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]-4-(hexa-2,5-dienyl)thiazole 
• 292073-56-4 4-hydroxymethyl-2-[(2-tert-butyldimethylsilyloxy)-1,1-dimethylethyl]thiazole 
• 292073-43-9 4-bromomethyl-2-[(2-tert-butyldimethylsilyloxy)-1,1-dimethylethyl]thiazole 
• 934989-91-0 2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]-4-hex-5-en-2-ynylthiazole 
• 934989-90-9 2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]-4-prop-2-ynylthiazole 
• 934989-89-6 ethyl 2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethylethyl]thiazol-4-carboxylate 
• 934989-99-8 ethyl 2-[2-(tert-butyldiphenylsilyloxy)-1,1-dimethyl]-4-hydroxy-4,5-dihydrothiazol-4-carboxylate 
• 934989-98-7 3-(tert-butyldiphenylsilyloxy)-2,2-dimethylpropanethioamide 
• 934989-88-5 3-(tert-butyldiphenylsilyloxy)-2,2-dimethylpropanamide 

Relevant articles and documents

Asymmetric total synthesis of (-)-mycothiazole.

[structure: see text] In this Letter we describe the first total synthesis of mycothiazole, a polyketide thiazole from a marine sponge. Key steps include our CMD oxidation for the conversion of thiazolidine 11 to thiazole 12 and the Nagao acetate aldol re

NITROGENATED HETEROCYCLIC COMPOUND

The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.

DIAMINE DERIVATIVES

A compound represented by formula (1):Q1-Q2-To-N(R1) -Q3-N(R2)-T1-Q4 [wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 represents the following group: (wherein Q5 is an alkylene group having 1 to 8 carbon atoms, or the like); and T0 and T1 are carbonyl groups or the like], a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.